Product image of Tolterodine Tartrate 4 mg/1 (Tolterodine Tartrate) 4 mg/1 CAPSULE, EXTENDED RELEASE supplied by GNH India

Tolterodine Tartrate 4 mg/1

Active Ingredient:
Tolterodine Tartrate
Form:
CAPSULE, EXTENDED RELEASE
Brand:
Tolterodine Tartrate
Origin:
USA

Tolterodine Tartrate 4 mg/1 (Tolterodine Tartrate CAPSULE, EXTENDED RELEASE) 4 mg/1

Tolterodine tartrate, the active ingredient in Tolterodine Tartrate, is an antimuscarinic (anticholinergic) presented as a 4 mg/1 extended-release capsule for oral use. It is used to treat symptoms of overactive bladder, including urinary incontinence, urgency, and frequency. GNH India supplies Tolterodine Tartrate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Tolterodine Tartrate is a prescription medication designed to manage overactive bladder symptoms by reducing bladder muscle spasms. It is available in extended-release capsules, ensuring a controlled release of the active ingredient over time.

Strength

4 mg/1

Pack Size

500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-7164-05)

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Tolterodine Tartrate is an antimuscarinic medication used to manage symptoms of overactive bladder. It helps to reduce involuntary bladder contractions, which can lead to urinary incontinence, urgency, and frequency.

  • Overactive bladder: Reduces the frequency of urinary urgency and incontinence.
  • Urgency urinary incontinence: Helps control sudden, uncontrollable urges to urinate.
  • Urinary frequency: Decreases the number of times a person needs to urinate.

How It Works

  • Tolterodine tartrate works by acting as a competitive antagonist of muscarinic (M2, M3) receptors in the bladder detrusor muscle. By blocking these receptors, it reduces involuntary contractions of the bladder, thereby alleviating symptoms of overactive bladder.

Side Effects

Tolterodine Tartrate may cause several side effects, ranging from common to serious or rare. Common Side Effects:

  • Dry mouth
  • Headache
  • Constipation
  • Abdominal pain
  • Dry eyes
  • Accommodation abnormalities

Serious or Rare Side Effects

  • Urinary retention
  • Severe constipation
  • Allergic reactions
  • Angioedema
  • Anaphylaxis

Precautions & Warnings

Tolterodine Tartrate should be used with caution in certain populations and conditions. Always follow the advice of a healthcare professional. Consult a doctor before use if:

  • Allergic to tolterodine or any of the ingredients: Avoid use if you have a known allergy.
  • Glaucoma: Use with caution as it may worsen symptoms.
  • Urinary retention: Monitor closely for signs of urinary retention.
  • Gastrointestinal obstruction: Use with caution as it may exacerbate conditions.
  • Store at 20–25°C (68–77°F): Protect from light and keep in a dry place.

Avoid Interactions

Tolterodine Tartrate may interact with other medications, potentially altering its effectiveness or increasing the risk of side effects. Major Interactions (Avoid):

  • Anticholinergic drugs: May increase the risk of side effects such as dry mouth and constipation.
  • CYP3A4 inhibitors: May increase the concentration of tolterodine in the blood.
  • CYP2D6 inhibitors: May alter the metabolism of tolterodine.

Moderate Interactions (Monitor Closely)

  • Antifungals: May increase the risk of side effects.
  • Antibiotics: May alter the metabolism of tolterodine.
  • Antidepressants: May increase the risk of side effects.

Frequently Asked Questions

Tolterodine Tartrate is used to treat symptoms of overactive bladder, including urinary incontinence, urgency, and frequency. It works by reducing involuntary bladder contractions, helping to control these symptoms.

Tolterodine Tartrate acts as a competitive antagonist of muscarinic (M2, M3) receptors in the bladder detrusor muscle. By blocking these receptors, it reduces involuntary contractions of the bladder, thereby alleviating symptoms of overactive bladder.

The usual recommended dose of Tolterodine Tartrate is 4 mg once daily. The dose may be reduced to 2 mg once daily based on individual response and tolerability. The prescriber will determine the appropriate dose for each patient.

Tolterodine Tartrate is classified as a pregnancy category C drug, meaning it should be used during pregnancy only if the potential benefits outweigh the risks. It is not recommended for use during breastfeeding. Always consult a healthcare professional for personalized advice.

To order Tolterodine Tartrate from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

Tolterodine Tartrate is an antimuscarinic medication that works by blocking muscarinic receptors in the bladder. It is similar to other antimuscarinic drugs like oxybutynin and solifenacin, but the choice of medication depends on individual patient response and tolerability.

Tolterodine Tartrate should be stored at 20–25°C (68–77°F), with brief excursions permitted between 15–30°C (59–86°F). Protect from light and keep in a dry place. Always follow the storage instructions provided on the packaging.

Tolterodine Tartrate is administered orally as an extended-release capsule. The capsules should be swallowed whole, not crushed or chewed, and can be taken with or without food. Always follow the dosage instructions provided by your healthcare professional.

The most serious risks associated with Tolterodine Tartrate include urinary retention, severe constipation, allergic reactions, angioedema, and anaphylaxis. If you experience any of these symptoms, seek medical attention immediately.

Tolterodine Tartrate should not be used by individuals who are allergic to tolterodine or any of the ingredients in the medication. It should also be used with caution in patients with glaucoma, urinary retention, and gastrointestinal obstruction. Always consult a healthcare professional before starting any new medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tolterodine Tartrate

Zepbound 2.5 mg/.5mL

Zepbound 2.5 mg/.5mL

2.5 mg/.5mL INJECTION, SOLUTION
Zepbound 2.5 mg/.5mL

Zepbound 2.5 mg/.5mL

2.5 mg/.5mL INJECTION, SOLUTION
Zepbound 2.5 mg/.5mL

Zepbound 2.5 mg/.5mL

2.5 mg/.5mL INJECTION, SOLUTION
Humulin R 100 [iU]/mL

Humulin R 100 [iU]/mL

100 [iU]/mL INJECTION, SOLUTION

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT